DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Viral Clearance Market by Application, Method (Inactivation, Removal, Detection (PCR, ELISA)) & End User - Global Forecast to 2020 " report to their offering.
The global viral clearance market is projected to reach USD 510.3 million by 2020 from USD 285.5 million in 2015, at a CAGR of 12.3% from 2015 to 2020.
The major drivers for the market include increase in pharmaceutical and biological industries and increasing number of new drug launches. Over the years, the number of drug approvals in North American countries has increased from 2006 to 2015. The increasing number of drug approvals will boost the viral clearance market.
This report segments the global viral clearance market based on method, end user, application, and geography. The method segments included in the report are viral detection method, viral removal method, and viral inactivation method. The viral detection method is further sub-segmented in to plaque assays, PCR, ELISA, and other viral detection method.
The application segments included in the report are blood & blood products, cellular & gene therapy products, stem cell products, tissue & tissue products, and vaccines and therapeutics. Based on end user this market is categorized into pharmaceutical and biotechnology companies, contract research organizations, academic research institutes, and other end users.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Viral Clearance Market, By Application
7 Viral Clearance Market, By End User
8 Viral Clearance Market, By Method
9 Viral Clearance Market, By Region
10 Competitive Landscape
11 Company Profiles
- Avance Biosciences Inc.
- Bsl Bioservice
- Charles River Laboratories International, Inc.
- Clean Cells Inc.
- Lonza Group
- Merck Kgaa
- Sgs S.A.
- Sigma-Aldrich Corporation
- Texcell, Inc.
Wuxi Pharmatech (Cayman) Inc.
For more information visit http://www.researchandmarkets.com/research/rt4g4p/viral_clearance